EMA Highlights: Europe to support Zika trials
by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.
by Gary Finnegan: The European Medicines Agency has set up a task force on Zika virus in an effort to accelerate the development of new medicines and vaccines… read more.
by Thomas R. Collins: Standing at the center of a decade and a half of stunning advancements in the treatment of multiple myeloma is the ubiquitin proteasome pathway… read more.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s Committee for Medicinal… read more.
by Gary Finnegan: The European Medicines Agency (EMA) says its powers are limited when it comes to regulating off-label use of licensed medicines. The watchdog is at the… read more.
Non-adherence with immunosuppressive treatment is potentially one of the most significant risk factors for intra-patient variability (IPV) in drug concentrations – and one that is modifiable. The link… read more.
by Gary Finnegan: Ireland: Medicines routinely prescribed for older patients may be contributing to elevated rates of falls in elderly men, according to a study published in the… read more.
by Gary Finnegan: EU agencies are stepping up cooperation with the World Health Organization (WHO) to share information on the safety, quality and efficacy of medicines.
by Gary Finnegan: The chair of the European Medicine Agency’s most influential committee has been re-elected for a three-year term. The Committee for Medicinal Products for Human Use… read more.
by Gary Finnegan: The European Medicines Agency’s key committee approved a total of 19 new medicines at its meeting in late September – the highest number of products… read more.
by Gary Finnegan: The European Medicines Agency is waging a fierce battle against the EU’s own employment court over the controversial 2011 appointment of its former Executive Director.
by Gary Finnegan: The European Medicines Agency wants to get new medicines to patients quicker where there is a clear unmet medical need. The move could also see… read more.
Advertisment